News

Tractor Supply Co.’s Stock Drops 5% as Earnings Fall Below Expectations

1 Mins read

Tractor Supply Co., the leading retailer of farm and ranch products, experienced a significant drop in its stock (TSCO, -0.08%) by 5% during Thursday’s early trading session. The Brentwood, Tennessee-based company reported a net income of $255 million, or $2.33 per share, for the quarter, an increase from $234.1 million, or $2.10 per share, in the same period last year. Despite this growth, sales only rose by 4.3% to reach $3.41 billion.

Unfortunately, Tractor Supply’s earnings fell short of the FactSet consensus, with analysts expecting earnings per share (EPS) of $2.29 and sales amounting to $3.47 billion. CEO Hal Lawton acknowledged the disappointing performance, stating that sales were lower than anticipated due to various factors affecting consumer spending. He added, “Given this environment, we have revised our outlook for the year to account for continued unfavorable seasonal category performance and cautious consumer spending.”

As a result, Tractor Supply Co. revised its full-year guidance, projecting EPS between $10.00 and $10.10 compared to the previous range of $10.20 to $10.40. The company also lowered its sales forecast to a range of $14.5 billion to $14.6 billion, down from the initial guidance of $14.8 billion to $14.9 billion. Furthermore, the company expects same-store sales to remain flat, contrary to the previous forecast of a 1.3% to 2.5% increase.

Since the beginning of the year, Tractor Supply’s stock has experienced a decline of 12%, in contrast to the S&P 500 (SPX, -1.43%), which has seen a 9% increase.

Related posts
News

GitLab Stock Surges on First Ever Adjusted Operating Profit

1 Mins read
GitLab’s stock experienced a significant surge on Tuesday following the announcement of its first ever adjusted operating profit. Despite this positive development,…
News

Virgin Galactic Faces Stock Decline Amid Founder's Money Decision

2 Mins read
Virgin Galactic stock experienced a sharp decline in early trading on Monday due to founder Richard Branson’s announcement that he won’t be…
News

EyePoint Pharmaceuticals Announces Positive Results in Phase 2 Trial for Macular Degeneration Treatment

1 Mins read
EyePoint Pharmaceuticals, a Massachusetts-based company, revealed exciting news on Monday regarding the second-phase trial of its investigational treatment for macular degeneration. The…

Leave a Reply

Your email address will not be published. Required fields are marked *

47 + = 50